Philip Morris International Comments on Court of Justice of the European Union Judgment on the EU Tobacco Products Directive
Philip Morris International (NYSE/Euronext Paris: PM) today comments on the judgment of the Court of Justice of the European Union following its legal review of the EU’s Tobacco Products Directive (“TPD”).
Marc Firestone, Senior Vice President and General Counsel of Philip Morris International, said:
“Today’s judgment is specific to detailed aspects of EU law, and reflects the substantial deference that the Court of Justice often shows to the EU institutions when reviewing EU legislation.”
The Court’s opinion clarifies that the TPD does not necessarily preclude a Member State from adopting plain packaging, providing it can show that the measure respects private property, a competitive marketplace, and consumer access to information, and that it complies with domestic, European, and international law.
PMI and Member States participating in the case were seeking clarity on certain provisions of the TPD that appear to disrupt the balance of authority that the EU Treaties establish between the EU and the Member States, and violate the internal market principles upon which the EU was established.
Firestone continued, “The Court has not considered whether plain packaging is legal or is capable of reducing smoking rates. Those questions are currently under review by the English High Court and the World Trade Organization. We look forward to the outcome of those proceedings, as well as the timely implementation of the Directive in each of the 28 Member States.”
About Philip Morris International Inc. (“PMI”)
PMI is the world’s leading international tobacco company, with six of the world's top 15 international brands and products sold in more than 180 markets. In addition to the manufacture and sale of cigarettes, including Marlboro , the number one global cigarette brand, and other tobacco products, PMI is engaged in the development and commercialization of Reduced-Risk Products (“RRPs”). RRPs is the term PMI uses to refer to products with the potential to reduce individual risk and population harm in comparison to smoking cigarettes. Through multidisciplinary capabilities in product development, state-of-the-art facilities, and industry-leading scientific substantiation, PMI aims to provide an RRP portfolio that meets a broad spectrum of adult smoker preferences and rigorous regulatory requirements. For more information, see www.pmi.com and www.pmiscience.com .
Philip Morris International media office
T: +41 058 242 4500
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skrive dig op her og du vil løbende modtage pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
IPSEN16.1.2018 23:08 | pressemeddelelse
Ipsen and Exelixis announce phase 3 trial results of cabozantinib demonstrating significant overall survival benefit in patients with previously treated advanced hepatocellular carcinoma
NY-IFF16.1.2018 22:18 | pressemeddelelse
IFF to Release Fourth Quarter & Full Year 2017 Results February 14
CA-PATIENT-SAFETY-MVMNT16.1.2018 20:19 | pressemeddelelse
President Clinton to Address Healthcare Leaders Focused on Eliminating Preventable Deaths in Hospitals at the 6th Annual World Patient Safety, Science & Technology Summit
DISARONNO16.1.2018 17:08 | pressemeddelelse
Disaronno: The Mixing Star Makes a Step Change and Looks to Innovation
NY-CHRISTIE’S16.1.2018 16:57 | pressemeddelelse
Christie’s Announces Public Preview Tour Dates for The Collection of Peggy and David Rockefeller
MA-CONTINUUM16.1.2018 16:02 | pressemeddelelse
Continuum Accelerates Global Expansion with Portland Europe
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum